PRKN and cancer: Decreased p62 levels under hypoxia in the Nrf2/Siah2- and Parkin/Hsc70-dependent pathways are of interest because the suppression of p62 is critical for cancer cell survival under hypoxia and, thus, may serve as a novel target for solid tumors.